Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Respiratory Devices Market

Therapeutic Respiratory Devices Market Size - By Product (Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators, Inhalers, Nebulizers, Humidifiers), By Application (COPD, Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis), By End-use - Global Forecast (2023-2032)

  • Report ID: GMI696
  • Published Date: Jun 2023
  • Report Format: PDF

Therapeutic Respiratory Devices Market Size

Therapeutic Respiratory Devices Market size was worth more than USD 47 billion in 2022 and is poised to exhibit 4.7% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.

Therapeutic Respiratory Devices Market

In recent years, respiratory diseases have turned to be the major cause of mortality in both developing and underdeveloped nations. There has also been a rapid rise in the number of non-contagious respiratory disorders, such as asthma, COPD, cystic fibrosis, and lung cancer. As per the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2022, more than 350 million people worldwide suffer from asthma. Furthermore, the rising levels of air pollution is increasing the burden of lung and respiratory ailments.

Therapeutic respiratory devices play a pivotal role in managing respiratory diseases, by providing much-needed relief and improving the quality of life for patients. These devices encompass a wide range of tools, including inhalers, nebulizers, positive airway pressure machines, and oxygen concentrators. Additionally, the advent of medically advanced respiratory devices has revolutionized the treatment of respiratory diseases for improved respiratory functions and enhanced overall well-being.

COVID-19 Impact

The COVID-19 pandemic proved beneficial to the demand for therapeutic respiratory devices. The increasing spread of the infection by respiratory droplets and the rising impacts on the respiratory system led to the surging adoption of respiratory medical devices. Furthermore, the influx of new product improvements and launches to meet the rising demand boosted the market expansion. For instance, the U.S. FDA granted emergency authorization to use Vesper, a device created by Prisma Health for sustaining up to four patients on a ventilator.

Therapeutic Respiratory Devices Market Trends

The increasing R&D spending on different technical breakthroughs in therapeutic respiratory devices will accelerate the market development. Advanced respiratory devices allow patients to utilize practical and user-friendly gadgets for the treatment of various respiratory disorders. Furthermore, the demand for portable and miniaturized therapeutic ventilators is picking pace as they are quick, affordable, and may be used outdoors without the supervision of doctors.

Therapeutic Respiratory Devices Market Analysis

Therapeutic Respiratory Devices Market Size, By Product, 2021-2032 (USD Billion)

Therapeutic respiratory devices market size from the inhalers product segment is expected to generate more than USD 40 billion in revenue by the end of 2032. The higher availability of newly developed automated inhalers, including metered-dose inhalers, dry powder inhalers, and soft mist inhalers for aiding the administration of appropriate quantities of drugs to patients has boosted the demand for inhalers. 

Therapeutic Respiratory Devices Market Share, By Application, 2022

Based on application, the asthma segment in the therapeutic respiratory devices market share is estimated to record USD 19 billion through 2032. This can be attributed to the rising prevalence of chronic illness affecting children worldwide, including asthma. According to the Asthma and Allergy Foundation of America, around 25 million individuals in the U.S. suffer from asthma, accounting for nearly one in every thirteen people. The rising incidence of asthma worldwide has spurred the demand for inhalers and nebulizers.

U.S. Therapeutic Respiratory Devices Market Size, 2020-2032 (USD Billion)

North America therapeutic respiratory devices market size is poised to expand at over 3.5% CAGR by 2032. The industry development can be ascribed to the growing frequency of respiratory disorders, higher availability of modern healthcare infrastructure, and the presence of leading market players across the region. Also, the widespread adoption of new technologies among patients along with favorable reimbursement circumstances may augment the industry outlook.

Therapeutic Respiratory Devices Market Share

Some of the major companies operating in the therapeutic respiratory devices market include

  • Hill-Rom Services Inc. (Baxter)
  • ResMed Inc.
  • Drägerwerk AG & Co. KGaA
  • Hamilton Medical
  • Koninklijke Philips N.V.
  • Invacare Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Breas Medical AB
  • ICU Medical
  • Medtronic
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare


Therapeutic Respiratory Devices Industry News

  • In September 2022, Aerin Medical Inc., introduced RhinAer Stylus, an FDA-approved noninvasive radiofrequency approach that addresses the causes of chronic rhinitis postnasal drip, runny nose, and nasal congestion.

The therapeutic respiratory devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market Size, By Product

  • Positive airway pressure (PAP) devices
    • Continuous positive airway pressure (CPAP) devices
    • Auto-titrating positive airway pressure (APAP) devices
    • Bi-level positive airway pressure (BiPAP) devices
  • Oxygen concentrator
    • Fixed oxygen concentrators
    • Portable oxygen concentrators
  • Ventilators
    • Adult ventilators
    • Neonatal ventilators
  • Inhalers
    • Metered dose inhaler (MDI)
    • Dry powder inhaler (DPI)
    • Soft mist inhaler (SMI) 
  • Nebulizers
    • Compressor-based nebulizers
    • Piston-based hand-held nebulizers
    • Ultrasonic nebulizers
  • Humidifiers
    • Heated humidifiers
    • Passover humidifiers
    • Integrated humidifiers
    • Built-in humidifiers
    • Standalone humidifiers  
  • Others

Market Size, By Application

  • COPD
  • Obstructive sleep apnea
  • Asthma
  • Respiratory distress syndrome
  • Cystic fibrosis
  • Others

Market Size, By End-use

  • Hospital
  • Homecare settings
  • Emergency centers

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE


Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market size for therapeutic respiratory devices was USD 47.2 billion in 2022 and is projected to record 4.7% CAGR by 2032 attributed to the high prevalence of respiratory diseases worldwide.

The inhalers product segment is expected to amass more than USD 40 billion by 2032 attributed to the increasing availability of newly developed automated inhalers.

North America therapeutic respiratory devices is set to exhibit growth at over 3.5% CAGR from 2023 to 2032 owing to the high frequency of respiratory disorders and the growing availability of modern healthcare infrastructure.

Some of the key therapeutic respiratory device providers include Hill-Rom Services Inc. (Baxter), ResMed Inc., Drägerwerk AG & Co. KGaA, Hamilton Medical, Koninklijke Philips N.V., VYAIRE MEDICAL, INC., Invacare Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Breas Medical AB

Therapeutic Respiratory Devices Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 625
  • Countries covered: 18
  • Pages: 330
 Download Free Sample